Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib for adult and pediatric patients 2 years of age and older with advanced or metastatic Medullary Thyroid Cancer (RET m), as detected by an FDA-approved test, who require systemic therapy
AACR FDA Approval Alert 09/30/2024
…